Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Kenichiro Miura

Biographic Data

ID7954142
NAMEKenichiro Miura
GIVEN NAMESKenichiro
FAMILY NAMEMiura
SIGNATUREMIURA K
AFFILIATIONSNational Institute of Mental Health
ORCID0000-0002-3722-7837
VERIFIEDYes
TOTAL WORKS2
TOTAL CITATIONS0
AUTHOR COUNT2
EDITOR COUNT0
FIRST PUBLICATION YEAR2021
LATEST PUBLICATION YEAR2022
H-INDEX0
  • Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics

    Open Access•Hikaru Hori, Norio Yasui‐Furukori et al.•ARTICLE•Frontiers in Psychiatry•2022

    In several clinical guidelines for schizophrenia, long-term use of anticholinergic drugs is not recommended. We investigated the characteristics of the use of anticholinergics in patients with schizophrenia by considering psychotropic prescription patterns and differences among hospitals. A cross-sectional, retrospective prescription survey at the time of discharge was conducted on 2027 patients with schizophrenia from 69 Japanese hospitals. We e…

  • Eye Movement Abnormalities in Major Depressive Disorder

    Open Access•Junichi Takahashi, Yoji Hirano et al.•ARTICLE•Frontiers in Psychiatry•2021

    Background: Despite their high lifetime prevalence, major depressive disorder (MDD) is often difficult to diagnose, and there is a need for useful biomarkers for the diagnosis of MDD. Eye movements are considered a non-invasive potential biomarker for the diagnosis of psychiatric disorders such as schizophrenia. However, eye movement deficits in MDD remain unclear. Thus, we evaluated detailed eye movement measurements to validate its usefulness a…

No prominent works on this page.

  • Eye Movement Abnormalities in Major Depressive Disorder

    Open Access•Junichi Takahashi, Yoji Hirano et al.•ARTICLE•Frontiers in Psychiatry•2021

    Background: Despite their high lifetime prevalence, major depressive disorder (MDD) is often difficult to diagnose, and there is a need for useful biomarkers for the diagnosis of MDD. Eye movements are considered a non-invasive potential biomarker for the diagnosis of psychiatric disorders such as schizophrenia. However, eye movement deficits in MDD remain unclear. Thus, we evaluated detailed eye movement measurements to validate its usefulness a…

  • Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics

    Open Access•Hikaru Hori, Norio Yasui‐Furukori et al.•ARTICLE•Frontiers in Psychiatry•2022

    In several clinical guidelines for schizophrenia, long-term use of anticholinergic drugs is not recommended. We investigated the characteristics of the use of anticholinergics in patients with schizophrenia by considering psychotropic prescription patterns and differences among hospitals. A cross-sectional, retrospective prescription survey at the time of discharge was conducted on 2027 patients with schizophrenia from 69 Japanese hospitals. We e…

Internal Medicine (2 works) · Medicine (2 works) · Psychiatry (2 works) · Anesthesia (1 works) · Anticholinergic (1 works) · Antipsychotic (1 works) · Audiology (1 works) · Biomarker (1 works) · Cohort (1 works) · Eye movement (1 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae